Return On Equity of Lexeo Therapeutics, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lexeo Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Lexeo Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -90%, a 57% decline year-over-year.
  • Lexeo Therapeutics, Inc. annual Return On Equity for 2024 was -65%, a 179% decline from 2023.
  • Lexeo Therapeutics, Inc. annual Return On Equity for 2023 was 82%, a 25% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Lexeo Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -90% -33% -57% 01 Jul 2025 30 Sep 2025
Q2 2025 -95% +9% +8.5% 01 Apr 2025 30 Jun 2025
Q1 2025 -86% -2879% -103% 01 Jan 2025 31 Mar 2025
Q4 2024 -65% -147% -179% 01 Oct 2024 31 Dec 2024
Q3 2024 -58% -106% -219% 01 Jul 2024 30 Sep 2024
Q2 2024 -103% -156% -297% 01 Apr 2024 30 Jun 2024
Q1 2024 2793% +2731% +4441% 01 Jan 2024 31 Mar 2024
Q4 2023 82% +16% +25% 01 Oct 2023 31 Dec 2023
Q3 2023 49% 01 Jul 2023 30 Sep 2023
Q2 2023 52% 01 Apr 2023 30 Jun 2023
Q1 2023 62% 01 Jan 2023 31 Mar 2023
Q4 2022 65% 01 Oct 2022 31 Dec 2022

Lexeo Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -65% -147% -179% 01 Jan 2024 31 Dec 2024
2023 82% +16% +25% 01 Jan 2023 31 Dec 2023
2022 65% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.